Form D · Biotechnology
Trinity Nuclein Rd III Investors LLC
Southlake, TX · CIK 0002003771
Offering snapshot reported Dec 18, 2023 · SEC filing
- Reported sold
- $1.39M Offering amount: $15M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 5, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2023 | Amendment | $1,394,728 | $0vs Dec 15, 2023 | 25 | SEC filing |
| Dec 15, 2023 | Initial | $1,394,728 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $97.6K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-499914
$1,394,728 x 7% - $97,630.96
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TPEG Securities, LLC | 146726 |
Source: Form D, filed Dec 18, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
TRINITY NUCLEIN RD III INVESTORS LLC
Investment adviser: TRINITY INVESTORS FUND ADVISORS, LLC
- Gross asset value
- $2.79M
- Beneficial owners
- 25
- ADV minimum commitment
- $50K
Reported in Form ADV on May 20, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
Filing source
Form ADV 2107310 · May 20, 2026 · Schedule D 7.B.(1), fund 805-9420606140
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sanjay Chandra | Executive |
| Daniel Meader | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Southlake, TX, 76092